Have your own idea? Try our Stock Screener
Over the last 7 days, the Biotech industry has remained flat, although notably AbbVie gained 7.2%. As for the the longer term, the industry is up 25% over the past 12 months. As for the next few years, earnings are expected to grow by 28% per annum.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 31 Oct 2024 | US$894.4b | US$113.6b | -US$35,812,239,881.01 | 18.6x | -25x | 7.9x |
Sat, 28 Sep 2024 | US$891.6b | US$113.2b | -US$35,989,290,216.71 | 21.3x | -24.8x | 7.9x |
Mon, 26 Aug 2024 | US$908.6b | US$113.2b | -US$35,874,993,723.21 | 23.6x | -25.3x | 8x |
Wed, 24 Jul 2024 | US$1.2t | US$164.5b | -US$28,071,798,540.98 | 28.8x | -43x | 7.3x |
Fri, 21 Jun 2024 | US$1.1t | US$164.4b | -US$27,914,641,228.07 | 27.5x | -40.7x | 6.9x |
Sun, 19 May 2024 | US$1.1t | US$164.6b | -US$26,835,738,666.64 | 23.9x | -42.8x | 7x |
Tue, 16 Apr 2024 | US$1.1t | US$164.3b | -US$23,399,965,626.52 | 21.4x | -46.9x | 6.7x |
Thu, 14 Mar 2024 | US$1.2t | US$167.4b | -US$22,015,596,093.89 | 18.8x | -54.1x | 7.1x |
Sat, 10 Feb 2024 | US$1.2t | US$169.3b | -US$26,269,121,791.87 | 19.8x | -44.2x | 6.9x |
Mon, 08 Jan 2024 | US$1.4t | US$204.8b | -US$22,501,061,722.00 | 20.5x | -63.1x | 6.9x |
Wed, 06 Dec 2023 | US$1.3t | US$204.6b | -US$22,051,652,521.00 | 19.3x | -57.6x | 6.2x |
Fri, 03 Nov 2023 | US$1.2t | US$206.8b | -US$20,351,431,827.00 | 17.2x | -59.7x | 5.9x |
Sun, 01 Oct 2023 | US$1.3t | US$207.4b | -US$13,122,605,528.00 | 17.1x | -95.8x | 6.1x |
Tue, 29 Aug 2023 | US$1.3t | US$207.6b | -US$12,455,656,838.00 | 17.5x | -102.5x | 6.1x |
Thu, 27 Jul 2023 | US$1.1t | US$186.8b | -US$16,232,873,446.00 | 14.3x | -69.8x | 6.1x |
Sat, 24 Jun 2023 | US$1.1t | US$186.2b | -US$16,162,116,001.00 | 13.6x | -70.3x | 6.1x |
Mon, 22 May 2023 | US$1.2t | US$186.0b | -US$15,898,792,960.00 | 13x | -72.5x | 6.2x |
Wed, 19 Apr 2023 | US$1.2t | US$198.4b | -US$3,275,992,798.00 | 13.4x | -358.6x | 5.9x |
Fri, 17 Mar 2023 | US$1.1t | US$199.1b | -US$4,760,446,272.00 | 13.3x | -238.2x | 5.7x |
Sun, 12 Feb 2023 | US$1.2t | US$202.7b | -US$201,937,721.00 | 16.4x | -5723.2x | 5.7x |
Tue, 10 Jan 2023 | US$1.1t | US$203.5b | US$1.7b | 13.8x | 685.5x | 5.6x |
Thu, 08 Dec 2022 | US$1.2t | US$202.6b | US$1.4b | 14.9x | 839.9x | 5.7x |
Sat, 05 Nov 2022 | US$1.1t | US$204.6b | US$3.6b | 14.2x | 299.5x | 5.3x |
Mon, 03 Oct 2022 | US$1.0t | US$206.2b | US$5.5b | 14.9x | 187.1x | 4.9x |
Wed, 31 Aug 2022 | US$1.0t | US$206.3b | US$7.3b | 14.4x | 141.1x | 5x |
Fri, 29 Jul 2022 | US$1.1t | US$211.2b | US$11.2b | 16.4x | 96.6x | 5.1x |
Sun, 26 Jun 2022 | US$1.1t | US$212.4b | US$11.1b | 15.4x | 95.1x | 4.9x |
Tue, 24 May 2022 | US$1.0t | US$212.6b | US$11.1b | 14.9x | 90.9x | 4.7x |
Thu, 21 Apr 2022 | US$1.2t | US$226.7b | US$14.8b | 18.1x | 84.2x | 5.5x |
Sat, 19 Mar 2022 | US$1.3t | US$222.3b | US$10.5b | 19.8x | 123.5x | 5.8x |
Mon, 14 Feb 2022 | US$1.3t | US$216.3b | US$6.0b | 21.8x | 209.6x | 5.8x |
Wed, 12 Jan 2022 | US$1.4t | US$212.1b | US$2.7b | 24.7x | 501.5x | 6.4x |
Fri, 10 Dec 2021 | US$1.4t | US$211.9b | US$3.0b | 25x | 464.4x | 6.7x |
Sun, 07 Nov 2021 | US$1.5t | US$204.6b | US$1.1b | 27.3x | 1366x | 7.2x |
1366x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 0.49% | |
Healthcare | -1.80% | |
Biotech | 0.47% | |
Biotech | 0.47% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ABBV AbbVie | US$201.50 | 7.2% +US$24.1b | 41.4% | PE67.2x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
INCY Incyte | US$73.93 | 13.4% +US$1.7b | 36.0% | PE438.5x | |
IBRX ImmunityBio | US$5.64 | 63.0% +US$1.5b | 73.5% | PS3003.4x | |
GILD Gilead Sciences | US$88.29 | 1.2% +US$1.3b | 10.1% | PE104.3x |